Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT), sold 25,208 shares at $16.85 ($425K) on 2025-12-04, disclosed to the SEC on 2025-12-08.
Scheduled sale ($425k) by Chief Commercial Ofc Imm Med under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.85 | 12,604 | $212K | 50.0% |
| 2 | $16.85 | 12,604 | $212K | 50.0% |
| Total | $16.85 avg | 25,208 | $425K | 100% |
| Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |
| ADPT | SELL | 2024-03-06 | $165K | — | Filing → |